Bernard Gilly
Founder and CEO @ GenSight Biologics
Paris, France
Bernard Gilly is a Series A investor at GenSight Biologics in Paris focused on Computer and Health Care. Bernard Gilly is the Founder and CEO of GenSight Biologics. He previously worked at Fovea Pharmaceuticals, Sanofi as a CEO.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Bernard Gilly invests in
Stages Bernard Gilly invests in
Countries Bernard Gilly invests in
Investment Focus
Industry
- Computer 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
- Semiconductor 1 (25%)
- Pharmaceutical 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
- Series C 1 (25%)
- Funding Round 1 (25%)
Country
- France 1 (25%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GrAI Matter Labs
|
GrAI Matter Labs (GML) is in the business of life-ready AI. Artificial Intelligence as close to natural as it gets. AI that feels alive. GrAI Matter Labs delivers brain-inspired chips that behave like humans do. That make machines assisting humans act, and react, in real time, live. Which optimizes energy and maximizes efficiency, saving time,money, and vital natural resources. Welcome to a AI-ready future, where robots, drones, autonomous vehicles, AR devices, surveillance cameras are smart, safe and convenient. Welcome to an optimized future. | $14M / Nov 23, 2020 | |
|
GrAI Matter Labs
|
GrAI Matter Labs (GML) is in the business of life-ready AI. Artificial Intelligence as close to natural as it gets. AI that feels alive. GrAI Matter Labs delivers brain-inspired chips that behave like humans do. That make machines assisting humans act, and react, in real time, live. Which optimizes energy and maximizes efficiency, saving time,money, and vital natural resources. Welcome to a AI-ready future, where robots, drones, autonomous vehicles, AR devices, surveillance cameras are smart, safe and convenient. Welcome to an optimized future. | $15M / Series A / Apr 12, 2018 | |
Sequoia Pharmaceuticals
|
Sequoia Pharmaceuticals is a private, venture-capital funded company founded in 2002. They are engaged in the discovery and development of novel antiviral therapeutics with a focus on combating drug-resistant HIV and HCV. They are also developing pharmacokinetic enhancers to improve the exposure of co-administered therapeutics. | $35M / Series C / Jan 09, 2007 | |
|
Sequoia Pharmaceuticals
|
Sequoia Pharmaceuticals is a private, venture-capital funded company founded in 2002. They are engaged in the discovery and development of novel antiviral therapeutics with a focus on combating drug-resistant HIV and HCV. They are also developing pharmacokinetic enhancers to improve the exposure of co-administered therapeutics. | $22M / Series B / Mar 20, 2005 |
Co-Investors
About GenSight Biologics
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy-based treatments of retinal degenerative diseases.Based on recent results obtained by the teams of its scientificfounders, the company develops innovative approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from very low vision or blindness.
GenSight Biologics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bernard Gilly
Founder and CEO
|
|||
Jean Bennett
Vice Chairman
|
|||
Jose Alain Sahel
Founder
|
|||
Julio Benedicto
Vice President, Marketing
|
|||
Luk Vandenberghe
Co-Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bernard Gilly invest in?
Bernard Gilly invests primarily in Computer, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bernard Gilly last invest?
The most recent investment recorded for Bernard Gilly closed in Nov 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
